CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
Control +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05084833
NCT05084833N/ACompleted

ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

Ann & Robert H Lurie Children's Hospital of Chicago·interventional·Posted Oct 20, 2021·Updated May 27, 2026

In Brief

A clinical study evaluating Control, Patient activation, and 1 other intervention for Colorectal Cancer and Early Detection of Cancer. Completed, enrolled 300 participants across 4 sites.

Detailed Summary

The primary purpose of this study is to assess the best method for encouraging high-risk cancer survivors to get screened for colorectal cancer at the recommended age.

Study Details

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 20, 2021
Enrollment StartFeb 14, 2022
Primary CompletionSep 30, 2025
Study CompletionOct 30, 2025
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 4.7 years ago

Interventions

Controlbehavioral

Electronic educational materials

Patient activationbehavioral

Interactive text messages with links to videos (e.g. colorectal cancer screening options, cost of colorectal cancer screening, perspective from a cancer survivor, why regular appointments are important for cancer survivors) and resources (e.g. helpful websites) are sent to participants

Primary care provider activationbehavioral

Faxed educational materials (e.g. current colorectal cancer screening recommendations, frequently asked questions, insurance letter template, cover letter with overview of patient's cancer treatment history) sent to primary care providers